Human VEGF-A(Vascular Endothelial Cell Growth Factor A) ELISA Kit
中文名称：人血管内皮细胞生长因子A(VEGF-A)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 31.25-2000 pg/mL
- 灵敏度： 18.75 pg/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人VEGF-A抗体包被于酶标板上，实验时样品（或标准品）中的人VEGF-A会与包被抗体结合。后依次加入生物素化的抗人VEGF-A抗体和辣根过氧化物酶标记的亲和素，抗人VEGF-A抗体与结合在包被抗体上的人VEGF-A结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，VEGF-A浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中VEGF-A的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 31.25-2000 pg/mL |
| 灵敏度 | 18.75 pg/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人VEGF-A，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 操作步骤 | |
| 数据处理 |
-
Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
-
Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine–Paracrine Loop
IF: 8.911 -
A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility
IF: 6.638Journal： Acta Biomaterialia (2019)PMID：31075515Reactivity：HumanSample Type：Cell culture supernatant -
MicroRNA-142-3p suppresses endometriosis by regulating KLF9-mediated autophagy in vitro and in vivo
IF: 5.477 -
Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications
IF: 4.471 -
Sapylin (OK-432) alters inflammation and angiogenesis in vivo and vitro
IF: 3.743Journal： BIOMEDICINE & PHARMACOTHERAPY (2019)PMID：30844656Reactivity：HumanSample Type：Wound drainage fluid -
Effect of Diosmin Administration in Patients with Chronic Venous Disorders on Selected Factors Affecting Angiogenesis
IF: 3.060 -
Association of IGF1 and VEGFA polymorphisms with diabetic retinopathy in Pakistani population
IF: 2.996 -
The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers
IF: 2.663Journal： INVESTIGATIONAL NEW DRUGS (2019)PMID：30632005Reactivity：HumanSample Type：Cell culture medium -
Vascular endothelial growth factor and pulmonary hypertension in children with beta thalassemia major
IF: 1.689
暂无文件，请在搜索框输入识别码查询相关文件
| 名称 | 状态 | 有效期至 | 操作 | |
|---|---|---|---|---|
| {{item.文件名}} | {{item.status_str}} | {{item.timestamp_str}} | 点击查看 点击预览 |
*注：请在有效期内下载相关文件，过期后页面内将不提供文件下载及预览！
实验操作视频
